← Leaderboards
Debkishore Mitra
Lucira Health, Inc
$2,444,145
Attributed
$4,888,290
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2016–21$2M$1.5M$1M$500K$0
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$4,888,290 · 3
By mechanism
R44$4,888,290 · 3
Top collaborators
- Deborah Anne Dean6 shared
Most similar at Lucira Health, Inc
Same institution · by research overlap
- Ivan Dimov$448,628
- Sheena Devika Singh$491,497
Others in their field
Top investigators on “Infection”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,939,185
- Lawrence Corey · Fred Hutchinson Cancer Center$789,608,171
- Judith S. Currier · University Of California Los Angeles$511,038,212
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$463,711,983
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$415,229,497
Research focus
InfectionInstrumentEquipmentHeadInfertilityFollow-UpDiagnosticEctopic PregnancyEnsureCross ReactivityCitiesDiagnosisDetectionDesignAntibioticsChronic Pelvic PainEarly DiagnosisClinicChemistryAccident And Emergency DepartmentChlamydia TrachomatisCostBloodLead
Grant awards (6)
Low-Cost Instrument-free Point-of-Care Test for Chlamydia and Gonorrhea$991,343
R44 · FY2021 · AI · contact PI
Low-Cost Instrument-free Point-of-Care Test for Chlamydia and Gonorrhea$999,228
R44 · FY2020 · AI · contact PI
Low-Cost Instrument-free Point-of-Care Diagnostic for Neisseria gonorrhoeae$776,968
R44 · FY2018 · AI · contact PI
Low-Cost Instrument-free Point-of-Care Diagnostic for Neisseria gonorrhoeae$716,689
R44 · FY2017 · AI · contact PI
Low-Cost Instrument-free Point-of-care Platform for Multiplexed Chlamydia Diagnostics$696,136
R44 · FY2017 · AI · contact PI
Low-Cost Instrument-free Point-of-care Platform for Multiplexed Chlamydia Diagnostics$707,926
R44 · FY2016 · AI · contact PI